AGIO
Agios PharmNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.47B
P/E Ratio
—
EPS
$-7.12
Beta
0.79
52W High
$46.00
52W Low
$22.24
50-Day MA
$29.72
200-Day MA
$33.39
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
2.47
PEG Ratio
0.00
About Agios Pharm
Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | $54.03M |
| Gross Profit (TTM) | $-291.85M |
| EBITDA | $-466.96M |
| Operating Margin | -609.00% |
| Return on Equity | -30.20% |
| Return on Assets | -19.90% |
| Revenue/Share (TTM) | $0.93 |
| Book Value | $20.41 |
| Price-to-Book | 1.22 |
| Price-to-Sales (TTM) | 27.30 |
| EV/Revenue | 11.82 |
| EV/EBITDA | -2.33 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 86.10% |
| Shares Outstanding | $59.47M |
| Float | $49.74M |
| % Insiders | 1.09% |
| % Institutions | 104.48% |
Historical Volatility
HV 10-Day
152.93%
HV 20-Day
109.59%
HV 30-Day
99.23%
HV 60-Day
73.05%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($41.50 target)
7
Buy3
HoldData last updated: 4/29/2026